Increased levels of interleukin-1 are detected in nasal secretions of volunteers during experimental rhinovirus colds

J Infect Dis. 1994 May;169(5):1007-13. doi: 10.1093/infdis/169.5.1007.

Abstract

The potential involvement of interleukin-1 (IL-1) in the pathogenesis of experimental rhinovirus colds was examined. Nasal lavages were recovered before and for 5 days after rhinovirus infection from 44 subjects, 22 of whom were randomized to receive prophylaxis with glucocorticoids, while the rest received placebo. Immunoreactive IL-1 beta was significantly increased in subjects who were infected and symptomatic compared with noninfected volunteers or subjects who were infected but asymptomatic. Concentrations of immunoreactive IL-1 beta correlated with levels of kinins and albumin in lavage fluids. Studies of IL-1 bioactivity established that most activity in lavages from infected subjects was IL-1 beta. Glucocorticoid prophylaxis did not inhibit IL-1 production, nor did it significantly affect the symptomatic response to infection or, in a subset of patients, neutrophil infiltration. These data are consistent with the hypothesis that IL-1 could contribute to the pathogenesis of rhinovirus infections.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adolescent
  • Adult
  • Common Cold / immunology*
  • Common Cold / microbiology
  • Common Cold / prevention & control
  • Female
  • Glucocorticoids / therapeutic use
  • Humans
  • Interleukin-1 / analysis*
  • Male
  • Nasal Mucosa / immunology
  • Nasal Mucosa / metabolism*
  • Rhinovirus / immunology*

Substances

  • Glucocorticoids
  • Interleukin-1